Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: GARY P GROBBEL who wrote (20677)	5/17/2004 8:18:06 AM
From: Guy.	Respond to of 120405

TREK should issue a PR. I hope they will do that in the next several hours.

To: GARY P GROBBEL who wrote (20677)	5/17/2004 8:50:55 AM
From: rrufff	Respond to of 120405

TVIN - keeps rolling along - another one off its high, will continue to benefit by the terrible environment - terror. State of Georgia Places $600,000 Order for Additional TVI Decontamination Systems Business Wire - May 17, 2004 08:01 GLENN DALE, MD, May 17, 2004 (BUSINESS WIRE) -- TVI Corporation (OTCBB: TVIN), a leading supplier of rapid deployment shelters and chemical/biological decontamination systems for the military, public health, and first response agencies, today announced that Georgia has placed a $600,000 order for an additional 68 TVI decontamination systems. The Georgia State Department of Health, Bioterrorism Preparedness Division, the agency charged with preparing the state's health care system for acts of biological and chemical terrorism, purchased the systems though the Fisher Scientific State Contract, Prime Vendor Program. The systems will be deployed at hospitals and health care facility across the state. These shelters will provide Georgia health care providers with state-of-the-art patient management and decontamination systems. "Georgia is the 14th state to standardize on TVI's equipment," stated Rick Priddy, TVI Corporation's President and CEO. "As with many of our other state wins, we believe this initial purchase will be followed by add-on orders to equip more hospitals and first responders throughout the state. Georgia's first responders are now equipped with products with advanced technology and confirmed performance." "We will to continue to sell decontamination, hospital surge capacity, and patient isolation systems used for infection control, to agencies in the United States and expand our penetration internationally. The threat of terror, accidents and natural disaster are dangers that we have the ability to prepare for and we will develop new products to ensure the world's safety. Our research and development budget will increase to close to $1 million in 2004 to meet the demand for safety products" Priddy continued. About TVI Corporation: TVI Corporation, located in Glenn Dale, Maryland, is a leading supplier of rapid deployment shelters and chemical/biological decontamination systems for the military, public health, and first response agencies. TVI is also a primary source to the military for thermal targets and thermal decoys. TVI's stock trades on the OTC Bulletin Board under the symbol "TVIN." The TVI designation is a service mark of TVI Corporation. Any other company and product names mentioned above are trade names and/or trademarks of their respective owners. Information contained in this press release constitutes forward-looking statements within the meaning of the securities laws and involves expectations, beliefs, plans, intentions or strategies regarding the future and speak only as of the date hereof. These statements may be identified by the use of forward-looking words or phrases such as "should", "believes", expects", "might result", and others. These forward-looking statements involve risks and uncertainties and are not guarantees of future performance, as actual results could differ materially from our current expectations. Such risks and uncertainties include achieving order and sales levels to fulfill revenue expectations; our ability to respond to changes in the counter-terrorism, military, public safety, and first responder communities; adverse changes in governmental regulations; expected costs or charges, certain of which may be outside the our control; the time and costs involved in the marketing and promotion for our products; the possible cancellation of existing orders for our products; general economic and business conditions; and competitive factors in our markets and industry generally. The foregoing list of important factors is not all-inclusive, as numerous other factors could cause or contribute to such differences, including, but not limited to, those set forth in our Annual Report to Stockholders, 10-KSB, 10-QSB, and other SEC filings. Readers are cautioned not to place undue reliance on these forward-looking statements. We assume no obligation to update any such forward-looking statements, whether as a result of new information, future events or otherwise. For more information concerning TVI, please visit us at: www.tvicorp.com. SOURCE: TVI Corporation TVI Corporation, Glenn Dale Richard Priddy, 301-352-8800 or: Investor Relations Mike Frank, 201-659-0101 mike@mikefrankassociates.com Customize your Business Wire news & multimedia to match your needs. Get breaking news from companies and organizations worldwide. Logon for FREE today at www.BusinessWire.com.

To: GARY P GROBBEL who wrote (20677)	5/17/2004 9:55:59 AM
From: RikRichter	Respond to of 120405

SOTK .90/1.05 reports 11th straight qtr. of profits and improved balance sheet. Only $10 mil. market cap and growing nanotech involvement: Sono-Tek Announces Its Annual Earnings - Eleventh Consecutive Profitable Quarter Monday May 17, 9:34 am ET MILTON, N.Y., May 17 /PRNewswire-FirstCall/ -- Sono-Tek Corporation (OTC Bulletin Board: SOTK - News) today announced sales of $3,501,594 for the year ended February 29, 2004 compared to $3,157,756 for the same period of last year, an increase of 11% or $343,838. For the three months ended February 29, 2004 the Company reported sales of $1,106,592 compared to sales of $923,729 for the same period of last year, an increase of 20% or $182,863. The increases in sales are due to rebound of the electronics market that the Company serves as well as diversification of the Company's product lines over the last two and one half years to include applications in the medical and nanotechnology areas. For the year ended February 29, 2004, the Company had operating income of $359,504 compared to $241,301 last year. For the year ended February 29, 2004, the Company had net income of $785,229 (which included a $585,000 tax benefit due to the recognition of a deferred tax asset) as compared to $120,956 last year. The Diluted earnings per share increased from $.01 for the year ended February 28, 2003 to $.07 for the year ended February 29, 2004. The Company's balance sheet is greatly improved from last year at this time with working capital at $786,459 at February 29, 2004 up from working capital of $527,085 last year, liabilities have been reduced from $2,074,807 at February 28, 2003 to $1,898,247 at February 29, 2004, and shareholders' equity improved markedly with a consolidated equity of $586,847 at February 29, 2004, up from an equity deficiency of $639,453 at February 28, 2003. The most significant factors in this change are improving operating income, exercise of warrants and stock options, conversion of debt to equity by several noteholders and the recognition of a net tax asset relating to net operating loss carryforwards. According to Dr. Christopher L. Coccio, Sono-Tek's CEO and President, "We have noted a resurgence in new business prospects during the last two quarters, particularly in the electronics markets with new orders for the Company's latest solder flux application system, the SonoFlux 2000F. We have sold many systems specifically designed for applying anti-restenosis drug coatings to arterial stents. Customers in the nanotechnology field continue to use our ultrasonic nozzle systems to apply nanophase liquids to their products and we are optimistic about additional opportunities in this growing business area. We are continuing to develop coating systems for medical device customers and other customers in a diverse range of industries from food processing to plate glass manufacturing." For further information, contact Dr. Christopher L. Coccio, at 845-795-2020, or visit our website at www.sono-tek.com. Sono-Tek Corporation is a leading developer and manufacturer of liquid spray products based on its proprietary ultrasonic nozzle technology. Founded in 1975, the Company's products have long been recognized for their performance, quality, and reliability. This earnings release contains forward looking statements regarding future events and the future performance of Sono-Tek Corporation that involve risks and uncertainties that could cause actual results to differ materially. These factors include, among other considerations, general economic and business conditions; political, regulatory, competitive and technological developments affecting the Company's operations or the demand for its products; timely development and market acceptance of new products; adequacy of financing; capacity additions and the ability to enforce patents. We refer you to documents that the company files with the Securities and Exchange Commission, which includes Form 10-KSB and Form 10-QSBs containing additional important information. Sono-Tek Corporation Selected Financial Data Year Ended February 29, February 28, 2004 2003 Net Sales $3,501,594 $3,157,756 Operating Income $359,504 $241,301 Net Income $785,229 $120,956 Basic Earnings per Share $0.08 $0.01 Diluted Earnings per Share $0.07 $0.01 Weighted Average Shares - Basic 9,248,175 9,152,401 Weighted Average Shares - Diluted 11,414,584 10,265,644